Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for tumor markers
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Dendritic cells derived from healthy donor monocytes induced by cord blood or tumor alfa fetoprotein
Most Relevant Literature
- Value of ctDNA methylation biomarkers in diagnosis of colorectal tumors.
- An accurate diagnostic approach for urothelial carcinomas based on novel dual methylated DNA markers…
- DNA methylation markers in the detection of hepatocellular carcinoma.
- A Prognostic Model of Genetic Markers for Triple-Negative Breast Cancer Based on Machine Learning an…
- GLDADec: marker-gene guided LDA modeling for bulk gene expression deconvolution.
Most Relevant Clinical Trials
- Terahertz Metamaterials for Tumour Marker Concentration Identification
- Lab-on-a-chip Detection of Cervical Cancer Tumour Markers
- The Relationship Between the Tumor Markers and Interstitial Lung Disease
- Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2…
